Helicos
The sequencing-by-synthesis platform, using technology originally developed by Helicos, was approved by China's NMPA for noninvasive prenatal testing earlier this year.
China NMPA Approves GeneMind GenoCare 1600 Sequencer for Noninvasive Prenatal Testing
The sequencer, produced by Chinese sequencing tech company GeneMind Biosciences, is approved for noninvasive prenatal testing to detect common trisomies.
SeqLL Withdraws Plans for $8M IPO
The Massachusetts sequencing firm has been selling technology originally developed by Helicos BioSciences and planned to increase marketing with the IPO proceeds.
The company is collecting validation evidence it intends to submit to the FDA next year, which will also support launch of the test as an LDT.
The company plans to raise $25 million in a Series B financing round. It is also working on a two-color chemistry and aims to develop an instrument for clinical applications.